12:00 AM
 | 
Jan 22, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Dendreon Corp.

(DNDN), Seattle, Wash.

Business: Cancer

UBS Warburg analyst Andrew Gitkin lowered his rating to...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >